American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 28, Issue 3 , Pages 153-157 , May 2007

Positron emission tomography: poor sensitivity for occult tonsillar cancer

Presented at the Annual Western Section Meeting of Triological Society in Las Vegas, NV, on February 5, 2005.

  • Vishad Nabili, MD

      Affiliations

    • Division of Head and Neck Surgery-Otolaryngology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA
    • ,
  • Brita Zaia, MD

      Affiliations

    • Division of Head and Neck Surgery-Otolaryngology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA
    • ,
  • Keith E. Blackwell, MD

      Affiliations

    • Division of Head and Neck Surgery-Otolaryngology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA
    • ,
  • Christian S. Head, MD

      Affiliations

    • Division of Head and Neck Surgery-Otolaryngology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA
    • ,
  • Karsten Grabski, MD

      Affiliations

    • Department of Nuclear Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA
    • ,
  • Joel A. Sercarz, MD

      Affiliations

    • Division of Head and Neck Surgery-Otolaryngology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA
    • Corresponding Author InformationCorresponding author. Division of Head and Neck Surgery-Otolaryngology, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, RM 62-132, CHS, Los Angeles, CA 90095, USA. Tel.: +1 310 825 5179.

Received 12 July 2006

References 

  1. Million RR, Cassisi NJ, Mancuso AA. In: Management of head and neck cancer: a multidisciplinary approach. Philadelphia: Lippincott Williams & Wilkins; 1994;p. 311–320
  2. Fu KK. Neck node metastases from unknown primary. Front Radiat Ther Oncol. 1994;28:66–78
  3. Greven KM, Keyes JW, Williams DW, et al. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-d-glucose. Cancer. 1999;86(1):114–118
  4. McGuirt WF, Greven K, Williams D, et al. PET scanning in head and neck oncology: a review. Head Neck. 1998;20(3):208–215
  5. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer. 1987;60(11):2682–2689
  6. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg. 1997;26(2):112–115
  7. Paulus P, Sambon A, Vivegnis D, et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope. 1998;108(10):1578–1583
  8. Bailet JW, Sercarz JA, Abemayor E, et al. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope. 1995;105(2):135–139
  9. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-d-glucose PET and MR imaging diagnoses. Radiology. 1996;200(1):135–141
  10. Kresnik E, Mikosch P, Gallowitsch HJ, et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med. 2001;28(7):816–821
  11. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer. 1994;73(12):3047–3058
  12. Assar OS, Fischbein NJ, Caputo GR, et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology. 1999;210(1):177–181
  13. Mukherji SK, Drane WE, Mancuso AA, et al. Occult primary tumors of the head and neck: detection with 2-[F-18]fluoro-2-deoxy-d-glucose SPECT. Radiology. 1996;199(3):761–766
  14. Hanasono MM, Kunda LD, Segall GM, et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope. 1999;109:880–885
  15. Safa AA, Tran LM, Rege S, et al. The role of positron emission tomography in occult primary head and neck cancers. Cancer J Sci Am. 1999;5(4):214–218
  16. Nakamoto Y, Sakamoto S, Okada T, et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology. 2005;234(3):879–885
  17. Wong WL, Saunders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol). 2003;15(8):461–466
  18. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409–1415
  19. Miller FR, Hussey D, Beeram M, et al. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2005;131:626–629
  20. Watanabe K, Nomori H, Ohtsuka T, et al. False negative cases of F-18 fluorodeoxyglucose–positron emission tomography (FDG-PET) imaging in small lung cancer less than 3cm in size. Chest. 2000;117(3):773–778
  21. Detterbeck FC, Falen S, Rivera MP, et al. Seeking a home for a PET, part 1: defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses. Ann Thorac Cardiovasc Surg. 2003;9(6):397–400

PII: S0196-0709(06)00162-1

doi: 10.1016/j.amjoto.2006.08.001

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 28, Issue 3 , Pages 153-157 , May 2007

Article Tools

* Image Usage & Resolution